Unitech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 11:58 pm

Competitors of Unitech Ltd

All Competitor Stocks of Unitech Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:50 am

Below is a detailed analysis of the quarterly data for Unitech Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 4.00 Cr..
• For Expenses, as of Jun 2025, the value is 115.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -674.00 Cr. (Mar 2025) to 115.00 Cr., marking an increase of 789.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 775.00 Cr. (Mar 2025) to -10.00 Cr., marking a decrease of 785.00 Cr..
• For OPM %, as of Jun 2025, the value is -9.00%. The value appears to be declining and may need further review. It has decreased from 768.00% (Mar 2025) to -9.00%, marking a decrease of 777.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 16.00 Cr..
• For Interest, as of Jun 2025, the value is 740.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,137.00 Cr. (Mar 2025) to 740.00 Cr., marking a decrease of 397.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -1.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -738.00 Cr.. The value appears to be declining and may need further review. It has decreased from -334.00 Cr. (Mar 2025) to -738.00 Cr., marking a decrease of 404.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 46.00% (Mar 2025) to 0.00%, marking a decrease of 46.00%.
• For Net Profit, as of Jun 2025, the value is -739.00 Cr.. The value appears to be declining and may need further review. It has decreased from -489.00 Cr. (Mar 2025) to -739.00 Cr., marking a decrease of 250.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -2.26. The value appears to be declining and may need further review. It has decreased from -1.18 (Mar 2025) to -2.26, marking a decrease of 1.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:36 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: June 16, 2025, 11:09 am

Below is a detailed analysis of the balance sheet data for Unitech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 523.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 523.00 Cr..
• For Reserves, as of Mar 2025, the value is -7,341.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -4,718.00 Cr. (Mar 2024) to -7,341.00 Cr., marking a decline of 2,623.00 Cr..
• For Borrowings, as of Mar 2025, the value is 7,321.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 7,230.00 Cr. (Mar 2024) to 7,321.00 Cr., marking an increase of 91.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 25,933.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23,485.00 Cr. (Mar 2024) to 25,933.00 Cr., marking an increase of 2,448.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 26,436.00 Cr.. The value appears to be improving (decreasing). It has decreased from 26,520.00 Cr. (Mar 2024) to 26,436.00 Cr., marking a decrease of 84.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 459.00 Cr.. The value appears to be declining and may need further review. It has decreased from 460.00 Cr. (Mar 2024) to 459.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 2,060.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,040.00 Cr. (Mar 2024) to 2,060.00 Cr., marking an increase of 20.00 Cr..
• For Other Assets, as of Mar 2025, the value is 23,715.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23,823.00 Cr. (Mar 2024) to 23,715.00 Cr., marking a decrease of 108.00 Cr..
• For Total Assets, as of Mar 2025, the value is 26,436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26,520.00 Cr. (Mar 2024) to 26,436.00 Cr., marking a decrease of 84.00 Cr..

However, the Borrowings (7,321.00 Cr.) are higher than the Reserves (-7,341.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Unitech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -9.91. This value is below the healthy minimum of 5. It has increased from -12.72 (Mar 24) to -9.91, marking an increase of 2.81.
• For Diluted EPS (Rs.), as of Mar 25, the value is -9.91. This value is below the healthy minimum of 5. It has increased from -12.72 (Mar 24) to -9.91, marking an increase of 2.81.
• For Cash EPS (Rs.), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 3. It has increased from -14.53 (Mar 24) to -12.13, marking an increase of 2.40.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -26.06. It has decreased from -16.03 (Mar 24) to -26.06, marking a decrease of 10.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -26.06. It has decreased from -16.03 (Mar 24) to -26.06, marking a decrease of 10.03.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.23. It has decreased from 1.82 (Mar 24) to 1.23, marking a decrease of 0.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -1.35. This value is below the healthy minimum of 2. It has increased from -2.78 (Mar 24) to -1.35, marking an increase of 1.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.37. This value is below the healthy minimum of 0. It has increased from -2.81 (Mar 24) to -1.37, marking an increase of 1.44.
• For PBT / Share (Rs.), as of Mar 25, the value is -11.58. This value is below the healthy minimum of 0. It has increased from -14.61 (Mar 24) to -11.58, marking an increase of 3.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -12.15. This value is below the healthy minimum of 2. It has increased from -14.55 (Mar 24) to -12.15, marking an increase of 2.40.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -9.91. This value is below the healthy minimum of 2. It has increased from -12.72 (Mar 24) to -9.91, marking an increase of 2.81.
• For PBDIT Margin (%), as of Mar 25, the value is -109.80. This value is below the healthy minimum of 10. It has increased from -152.66 (Mar 24) to -109.80, marking an increase of 42.86.
• For PBIT Margin (%), as of Mar 25, the value is -111.03. This value is below the healthy minimum of 10. It has increased from -153.96 (Mar 24) to -111.03, marking an increase of 42.93.
• For PBT Margin (%), as of Mar 25, the value is -941.69. This value is below the healthy minimum of 10. It has decreased from -800.99 (Mar 24) to -941.69, marking a decrease of 140.70.
• For Net Profit Margin (%), as of Mar 25, the value is -987.96. This value is below the healthy minimum of 5. It has decreased from -797.71 (Mar 24) to -987.96, marking a decrease of 190.25.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -806.20. This value is below the healthy minimum of 8. It has decreased from -697.01 (Mar 24) to -806.20, marking a decrease of 109.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.72. This value is below the healthy minimum of 10. It has decreased from 15.27 (Mar 24) to 4.72, marking a decrease of 10.55.
• For Return On Assets (%), as of Mar 25, the value is -9.81. This value is below the healthy minimum of 5. It has increased from -12.54 (Mar 24) to -9.81, marking an increase of 2.73.
• For Long Term Debt / Equity (X), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded -0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is -1.07. This value is within the healthy range. It has increased from -1.72 (Mar 24) to -1.07, marking an increase of 0.65.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Current Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1.5. It has decreased from 0.75 (Mar 24) to 0.69, marking a decrease of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 24) to 0.61, marking a decrease of 0.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 3. It has increased from -0.23 (Mar 24) to -0.13, marking an increase of 0.10.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.18. This value is below the healthy minimum of 3. It has increased from -0.23 (Mar 24) to -0.18, marking an increase of 0.05.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,928.76. It has decreased from 8,962.71 (Mar 24) to 6,928.76, marking a decrease of 2,033.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 21.54. This value exceeds the healthy maximum of 3. It has increased from 18.78 (Mar 24) to 21.54, marking an increase of 2.76.
• For EV / EBITDA (X), as of Mar 25, the value is -19.61. This value is below the healthy minimum of 5. It has decreased from -12.30 (Mar 24) to -19.61, marking a decrease of 7.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.81. This value exceeds the healthy maximum of 3. It has decreased from 6.14 (Mar 24) to 4.81, marking a decrease of 1.33.
• For Price / BV (X), as of Mar 25, the value is -0.22. This value is below the healthy minimum of 1. It has increased from -0.69 (Mar 24) to -0.22, marking an increase of 0.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.82. This value exceeds the healthy maximum of 3. It has decreased from 6.15 (Mar 24) to 4.82, marking a decrease of 1.33.
• For EarningsYield, as of Mar 25, the value is -1.67. This value is below the healthy minimum of 5. It has decreased from -1.13 (Mar 24) to -1.67, marking a decrease of 0.54.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness